The Monash project that IDT is involved with is for a vaccine based on mRNA technology.
Novavax is not a mRNA vaccine.
Is it possible for IDT with their current capabilities and manufacturing knowledge to be produce 2 different types of COVID vaccines at the same time, or is it one or the other?
Novavax and IDT Partnership, page-25
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.43M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $28.31K | 245.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18704 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 367359 | 5 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IDT (ASX) Chart |